Firebrick Pharma Limited (ASX:FRE)
Australia · Delayed Price · Currency is AUD 0.0650
+0.0020 (3.17%)
Oct 14, 2025, 10:31 AM AEST
Firebrick Pharma Market Cap
Firebrick Pharma has a market cap or net worth of 15.77 million as of October 13, 2025. Its market cap has increased by 39.25% in one year.
Market Cap
15.77M
Enterprise Value
14.79M
Revenue
515.51K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since January 28, 2022, Firebrick Pharma's market cap has decreased from 89.49M to 15.77M, a decrease of -82.37%. That is a compound annual growth rate of -37.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 15.77M | 21.08% |
| Dec 31, 2024 | 13.03M | 46.33% |
| Dec 29, 2023 | 8.90M | -77.12% |
| Dec 29, 2022 | 38.92M | -56.51% |
| Jan 28, 2022 | 89.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 101.12B |
| Pro Medicus | 31.93B |
| Cochlear | 18.57B |
| Sonic Healthcare | 10.66B |
| Ramsay Health Care | 7.42B |
| Telix Pharmaceuticals | 5.11B |
| Ansell | 4.73B |
| Mesoblast | 3.70B |